- Home
- PVLA vs TBLA Comparison
PVLA vs TBLA Comparison
Compare PVLA & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PVLA | TBLA |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PVLA | TBLA |
|---|---|---|
| Price | $124.94 | $3.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $161.13 | $5.00 |
| AVG Volume (30 Days) | 314.8K | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.95 |
| Revenue Next Year | N/A | $5.62 |
| P/E Ratio | ★ N/A | $42.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.23 | $2.63 |
| 52 Week High | $151.18 | $4.65 |
Technical Indicators
Market Signals| Indicator | PVLA | TBLA |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 39.28 |
| Support Level | $76.95 | $3.03 |
| Resistance Level | $151.18 | $3.56 |
| Average True Range (ATR) | 10.39 | 0.17 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 34.50 | 40.94 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About TBLA Taboola.com Ltd.
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.